Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 115 Pages
Report ld: 4406968
Request Sample
Customized Report
Urolithin A Market Size(US$)

CAGR 2025-2031
6.1%
Market Size,2031
USD 59.3
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Urolithin A was estimated to be worth US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Urolithin A is a natural compound with multiple biological activities. It is a yellow or light yellow solid powder at room temperature and pressure. It can be dissolved in highly polar organic solvents such as dimethyl sulfoxide and N,N-dimethylformamide, but has poor solubility in low-polar petroleum ether and ether, and also has poor solubility in water.
Urolithin A is a secondary metabolite of the natural polyphenol compound ellagitannin metabolized by intestinal microorganisms, and is also an intestinal microbial metabolite of ellagic acid. After the human body ingests ellagitannin and ellagic acid, urolithin A is metabolized by intestinal flora.
Urolithin A can inhibit the activity of nuclear factor κB (NF-κB), reduce the production of inflammatory factors, and thus reduce inflammatory damage. As a mitochondrial autophagy inducer, urolithin A can prevent muscle aging and promote cell health, thereby playing an anti-aging role. It can also inhibit the activity of telomerase and delay cell aging. Urolithin A can scavenge free radicals in the body, protect cells from oxidative damage, and maintain the normal physiological functions of the body. It can also bind to peroxisome proliferator-activated receptor γ (PPARγ) and activate the PPARγ signaling pathway, thereby enhancing the antioxidant capacity of cells.
With the improvement of people's living standards and the enhancement of health awareness, the demand for natural compounds with health functions continues to increase. Urolithin A, as a natural compound with multiple biological activities such as anti-inflammatory, anti-aging, and antioxidant, meets this market demand.
In recent years, scientific research on urolithin A has continued to deepen, revealing more of its biological activities and health benefits. These research results provide a solid theoretical basis for the application of urolithin A and promote the development of its market.
The continuous advancement of preparation technology, especially the research and development and application of new preparation processes such as biofermentation, has improved the preparation efficiency and purity of urolithin A, reduced production costs, and provided technical support for its wide application.
Urolithin A has broad application prospects in many fields such as dietary supplements, cosmetics, medicines, and health products. This wide range of application areas provides broad space for the market development of urolithin A.
This report aims to provide a comprehensive presentation of the global market for Urolithin A, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Urolithin A by region & country, by Type, and by Application.
The Urolithin A market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urolithin A.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Urolithin A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Urolithin A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Urolithin A in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Urolithin A Product Introduction
1.2 Global Urolithin A Market Size Forecast
1.2.1 Global Urolithin A Sales Value (2020-2031)
1.2.2 Global Urolithin A Sales Volume (2020-2031)
1.2.3 Global Urolithin A Sales Price (2020-2031)
1.3 Urolithin A Market Trends & Drivers
1.3.1 Urolithin A Industry Trends
1.3.2 Urolithin A Market Drivers & Opportunity
1.3.3 Urolithin A Market Challenges
1.3.4 Urolithin A Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Urolithin A Players Revenue Ranking (2024)
2.2 Global Urolithin A Revenue by Company (2020-2025)
2.3 Global Urolithin A Players Sales Volume Ranking (2024)
2.4 Global Urolithin A Sales Volume by Company Players (2020-2025)
2.5 Global Urolithin A Average Price by Company (2020-2025)
2.6 Key Manufacturers Urolithin A Manufacturing Base and Headquarters
2.7 Key Manufacturers Urolithin A Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Urolithin A
2.9 Urolithin A Market Competitive Analysis
2.9.1 Urolithin A Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Urolithin A Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urolithin A as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity: >98%
3.1.2 Purity: >99%
3.1.3 Others
3.2 Global Urolithin A Sales Value by Type
3.2.1 Global Urolithin A Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Urolithin A Sales Value, by Type (2020-2031)
3.2.3 Global Urolithin A Sales Value, by Type (%) (2020-2031)
3.3 Global Urolithin A Sales Volume by Type
3.3.1 Global Urolithin A Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Urolithin A Sales Volume, by Type (2020-2031)
3.3.3 Global Urolithin A Sales Volume, by Type (%) (2020-2031)
3.4 Global Urolithin A Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Additives
4.1.2 Cosmetics
4.1.3 Drugs and Supplements
4.1.4 Others
4.2 Global Urolithin A Sales Value by Application
4.2.1 Global Urolithin A Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Urolithin A Sales Value, by Application (2020-2031)
4.2.3 Global Urolithin A Sales Value, by Application (%) (2020-2031)
4.3 Global Urolithin A Sales Volume by Application
4.3.1 Global Urolithin A Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Urolithin A Sales Volume, by Application (2020-2031)
4.3.3 Global Urolithin A Sales Volume, by Application (%) (2020-2031)
4.4 Global Urolithin A Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Urolithin A Sales Value by Region
5.1.1 Global Urolithin A Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Urolithin A Sales Value by Region (2020-2025)
5.1.3 Global Urolithin A Sales Value by Region (2026-2031)
5.1.4 Global Urolithin A Sales Value by Region (%), (2020-2031)
5.2 Global Urolithin A Sales Volume by Region
5.2.1 Global Urolithin A Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Urolithin A Sales Volume by Region (2020-2025)
5.2.3 Global Urolithin A Sales Volume by Region (2026-2031)
5.2.4 Global Urolithin A Sales Volume by Region (%), (2020-2031)
5.3 Global Urolithin A Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Urolithin A Sales Value, 2020-2031
5.4.2 North America Urolithin A Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Urolithin A Sales Value, 2020-2031
5.5.2 Europe Urolithin A Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Urolithin A Sales Value, 2020-2031
5.6.2 Asia Pacific Urolithin A Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Urolithin A Sales Value, 2020-2031
5.7.2 South America Urolithin A Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Urolithin A Sales Value, 2020-2031
5.8.2 Middle East & Africa Urolithin A Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Urolithin A Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Urolithin A Sales Value and Sales Volume
6.2.1 Key Countries/Regions Urolithin A Sales Value, 2020-2031
6.2.2 Key Countries/Regions Urolithin A Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Urolithin A Sales Value, 2020-2031
6.3.2 United States Urolithin A Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Urolithin A Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Urolithin A Sales Value, 2020-2031
6.4.2 Europe Urolithin A Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Urolithin A Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Urolithin A Sales Value, 2020-2031
6.5.2 China Urolithin A Sales Value by Type (%), 2024 VS 2031
6.5.3 China Urolithin A Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Urolithin A Sales Value, 2020-2031
6.6.2 Japan Urolithin A Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Urolithin A Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Urolithin A Sales Value, 2020-2031
6.7.2 South Korea Urolithin A Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Urolithin A Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Urolithin A Sales Value, 2020-2031
6.8.2 Southeast Asia Urolithin A Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Urolithin A Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Urolithin A Sales Value, 2020-2031
6.9.2 India Urolithin A Sales Value by Type (%), 2024 VS 2031
6.9.3 India Urolithin A Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Daicel
7.1.1 Daicel Company Information
7.1.2 Daicel Introduction and Business Overview
7.1.3 Daicel Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Daicel Urolithin A Product Offerings
7.1.5 Daicel Recent Development
7.2 Suzhou Myland Pharm & Nutrition Inc.
7.2.1 Suzhou Myland Pharm & Nutrition Inc. Company Information
7.2.2 Suzhou Myland Pharm & Nutrition Inc. Introduction and Business Overview
7.2.3 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Product Offerings
7.2.5 Suzhou Myland Pharm & Nutrition Inc. Recent Development
7.3 Shenzhen Hygieia Biotech Co., Ltd
7.3.1 Shenzhen Hygieia Biotech Co., Ltd Company Information
7.3.2 Shenzhen Hygieia Biotech Co., Ltd Introduction and Business Overview
7.3.3 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Product Offerings
7.3.5 Shenzhen Hygieia Biotech Co., Ltd Recent Development
7.4 Wuhan Senwayer Century Chemical Co.,Ltd
7.4.1 Wuhan Senwayer Century Chemical Co.,Ltd Company Information
7.4.2 Wuhan Senwayer Century Chemical Co.,Ltd Introduction and Business Overview
7.4.3 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Product Offerings
7.4.5 Wuhan Senwayer Century Chemical Co.,Ltd Recent Development
7.5 Henan Chenli Biotechnology Co., LTD.
7.5.1 Henan Chenli Biotechnology Co., LTD. Company Information
7.5.2 Henan Chenli Biotechnology Co., LTD. Introduction and Business Overview
7.5.3 Henan Chenli Biotechnology Co., LTD. Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Henan Chenli Biotechnology Co., LTD. Urolithin A Product Offerings
7.5.5 Henan Chenli Biotechnology Co., LTD. Recent Development
7.6 Wuhan Hengheda Pharm Co., Ltd
7.6.1 Wuhan Hengheda Pharm Co., Ltd Company Information
7.6.2 Wuhan Hengheda Pharm Co., Ltd Introduction and Business Overview
7.6.3 Wuhan Hengheda Pharm Co., Ltd Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Wuhan Hengheda Pharm Co., Ltd Urolithin A Product Offerings
7.6.5 Wuhan Hengheda Pharm Co., Ltd Recent Development
7.7 Shenyang Hongjiuzhou Chemical Co., Ltd.
7.7.1 Shenyang Hongjiuzhou Chemical Co., Ltd. Company Information
7.7.2 Shenyang Hongjiuzhou Chemical Co., Ltd. Introduction and Business Overview
7.7.3 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Product Offerings
7.7.5 Shenyang Hongjiuzhou Chemical Co., Ltd. Recent Development
7.8 Shandong Airuike Chemical Co., Ltd.
7.8.1 Shandong Airuike Chemical Co., Ltd. Company Information
7.8.2 Shandong Airuike Chemical Co., Ltd. Introduction and Business Overview
7.8.3 Shandong Airuike Chemical Co., Ltd. Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Shandong Airuike Chemical Co., Ltd. Urolithin A Product Offerings
7.8.5 Shandong Airuike Chemical Co., Ltd. Recent Development
7.9 LEADER BIOCHEMICAL GROUP
7.9.1 LEADER BIOCHEMICAL GROUP Company Information
7.9.2 LEADER BIOCHEMICAL GROUP Introduction and Business Overview
7.9.3 LEADER BIOCHEMICAL GROUP Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 LEADER BIOCHEMICAL GROUP Urolithin A Product Offerings
7.9.5 LEADER BIOCHEMICAL GROUP Recent Development
7.10 Cofttek
7.10.1 Cofttek Company Information
7.10.2 Cofttek Introduction and Business Overview
7.10.3 Cofttek Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Cofttek Urolithin A Product Offerings
7.10.5 Cofttek Recent Development
7.11 Fengchen Group Co.,Ltd
7.11.1 Fengchen Group Co.,Ltd Company Information
7.11.2 Fengchen Group Co.,Ltd Introduction and Business Overview
7.11.3 Fengchen Group Co.,Ltd Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Fengchen Group Co.,Ltd Urolithin A Product Offerings
7.11.5 Fengchen Group Co.,Ltd Recent Development
7.12 Natural Micron Chem Tech Co., Ltd.
7.12.1 Natural Micron Chem Tech Co., Ltd. Company Information
7.12.2 Natural Micron Chem Tech Co., Ltd. Introduction and Business Overview
7.12.3 Natural Micron Chem Tech Co., Ltd. Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Natural Micron Chem Tech Co., Ltd. Urolithin A Product Offerings
7.12.5 Natural Micron Chem Tech Co., Ltd. Recent Development
7.13 Dalian Handom Chemicals Co.,Ltd
7.13.1 Dalian Handom Chemicals Co.,Ltd Company Information
7.13.2 Dalian Handom Chemicals Co.,Ltd Introduction and Business Overview
7.13.3 Dalian Handom Chemicals Co.,Ltd Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Dalian Handom Chemicals Co.,Ltd Urolithin A Product Offerings
7.13.5 Dalian Handom Chemicals Co.,Ltd Recent Development
7.14 Shaanxi LonierHerb Bio-Technology Co., Ltd.
7.14.1 Shaanxi LonierHerb Bio-Technology Co., Ltd. Company Information
7.14.2 Shaanxi LonierHerb Bio-Technology Co., Ltd. Introduction and Business Overview
7.14.3 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Product Offerings
7.14.5 Shaanxi LonierHerb Bio-Technology Co., Ltd. Recent Development
7.15 Aktin Chemicals
7.15.1 Aktin Chemicals Company Information
7.15.2 Aktin Chemicals Introduction and Business Overview
7.15.3 Aktin Chemicals Urolithin A Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Aktin Chemicals Urolithin A Product Offerings
7.15.5 Aktin Chemicals Recent Development
8 Industry Chain Analysis
8.1 Urolithin A Industrial Chain
8.2 Urolithin A Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Urolithin A Sales Model
8.5.2 Sales Channel
8.5.3 Urolithin A Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Urolithin A market is projected to grow from US$ 41.56 million in 2025 to US$ 62.54 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 160
USD 4900.00
(Single User License)
The global Urolithin A market size was US$ 41.56 million in 2025 and is forecast to reach a readjusted size of US$ 62.54 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 97
USD 4250.00
(Single User License)
The global market for Urolithin A was estimated to be worth US$ 41.56 million in 2025 and is projected to reach US$ 62.54 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 111
USD 3950.00
(Single User License)
The global Urolithin A market was valued at US$ 41.56 million in 2025 and is anticipated to reach US$ 62.54 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 144
USD 2900.00
(Single User License)
The global Urolithin A market is projected to grow from US$ 39.4 million in 2024 to US$ 59.3 million by 2031, at a CAGR of 6.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
The global market for Urolithin A was valued at US$ 39.4 million in the year 2024 and is projected to reach a revised size of US$ 59.3 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published Date: 2025-03-10
Pages: 100
USD 2900.00
(Single User License)
The global Urolithin A market size was US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 91
USD 4250.00
(Single User License)
Valued at US$ 41.6 million in 2024, the global Urolithin A market is forecast to reach US$ 59.3 million by 2030, at a CAGR of 6.1% during the forecast period.
Published Date: 2025-03-03
Pages: 151
USD 4900.00
(Single User License)
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published Date: 2024-09-11
Pages: 97
USD 2900.00
(Single User License)
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published Date: 2024-09-11
Pages: 124
USD 4350.00
(Single User License)
The global Urolithin A market is projected to grow from US$ 41.56 million in 2025 to US$ 62.54 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 160
The global Urolithin A market size was US$ 41.56 million in 2025 and is forecast to reach a readjusted size of US$ 62.54 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 97
The global market for Urolithin A was estimated to be worth US$ 41.56 million in 2025 and is projected to reach US$ 62.54 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 111
The global Urolithin A market was valued at US$ 41.56 million in 2025 and is anticipated to reach US$ 62.54 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 144
The global Urolithin A market is projected to grow from US$ 39.4 million in 2024 to US$ 59.3 million by 2031, at a CAGR of 6.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 158
The global market for Urolithin A was valued at US$ 39.4 million in the year 2024 and is projected to reach a revised size of US$ 59.3 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published: 2025-03-10
Pages: 100
The global Urolithin A market size was US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
Valued at US$ 41.6 million in 2024, the global Urolithin A market is forecast to reach US$ 59.3 million by 2030, at a CAGR of 6.1% during the forecast period.
Published: 2025-03-03
Pages: 151
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published: 2024-09-11
Pages: 97
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published: 2024-09-11
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now